ChEMBL ID: CHEMBL2108666
Mechanism of action: CD22 inhibitor
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Trials and conditions connected to YTTRIUM Y 90 EPRATUZUMAB TETRAXETAN